# ctDNA Methylation Application in Postoperative Relapse and Adjuvant Chemotherapy Efficacy Evaluation

> **NCT05536089** · — · RECRUITING · sponsor: **Singlera Genomics Inc.** · enrollment: 2000 (estimated)

## Conditions studied

- Cancer Colorectal

## Interventions

- **DIAGNOSTIC_TEST:** a multi-locus blood-based assay

## Key facts

- **NCT ID:** NCT05536089
- **Lead sponsor:** Singlera Genomics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-05
- **Primary completion:** 2028-09
- **Final completion:** 2028-12
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2024-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05536089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05536089, "ctDNA Methylation Application in Postoperative Relapse and Adjuvant Chemotherapy Efficacy Evaluation". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05536089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*